The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…


Diabetes drugs pop on January's TV ad spending list, but AbbVie's Humira stays at the top

Can Xarelto's trial win in artery disease help J&J keep rival Eliquis at bay?

Could Opdivo worries turn BMS into an M&A target? One analyst thinks so

BMS' Eliquis is 'relatively close' to snagging market lead from J&J's Xarelto, CEO says

Humira finishes year as strong as it started, grabbing No. 1 TV spender spot for December

Top 20 pharma brands dropped more than $2B on national TV ads last year

BMS' Opdivo jumps back into pharma's top 3 TV ad spenders for November

BMS to overhaul R&D, operations and manufacturing as it trots out Street-beating Q3

J&J clot fighter battles Pfizer/Bristol for warfarin switches in red-hot market share race

Portola touts new data on recently rejected Xarelto, Eliquis antidote